Categories: UniversityIndustryDrugBioTech
Biotech developing novel Treg therapies for autoimmune diseases
Investors 4
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.05.2023 | Series A | $43.75M | Forbion |
Mentions in press and media 9
| Date | Title | Description | Source |
| 20.12.2023 | Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia... | We've launched a new Fierce Biotech Fundraising Tracker for 2023 to track all the venture capital fl... | fiercebiot... |
| 16.05.2023 | Belgium-based Dualyx raises EUR 40 million in Series A | Zwijnaarde, Belgium-based biotechnology company which specializes in advancing immune modulators, Du... | vcbay.news... |
| 15.05.2023 | Dualyx raises €40 million to progress Treg therapies for aut... | May 15, 2023
May 15, 2023, Ghent, Belgium – Dualyx NV, a Ghent based biotech developing next genera... | htgf.de/en... |
| 15.05.2023 | Dualyx Raises €40M in Series A Funding | Dualyx, a Zwijnaarde, Belgium-based biotechnology company which specializes in advancing immune modu... | finsmes.co... |
| 15.05.2023 | Dualyx raises €40 million to progress Treg therapies for aut... | - | globenewsw... |
| 15.05.2023 | Forbion co-leads €40 million Series A in Dualyx | Naarden, The Netherlands and Munich, Germany, 15 May, 2023 – Forbion, a leading European life scienc... | forbion.co... |
| 15.05.2023 | Andera Partners co-leads a €40 million Series A of Dualyx, a... | Andera Partners co-leads a €40 million Series A financing of Dualyx NV, a Ghent, Belgium based biote... | anderapart... |
| 15.05.2023 |
Dualyx raises €40 million to progress Treg therapies for a... | Use of proceeds will enable the development of the Company’s lead autoimmune program DT-001, targeti... | fh-partner... |
| - | Dualyx | “About | Dualyx” | fastfounde... |
Reviews 0
